Mellaril and Sedation aggravated - a phase IV clinical study of FDA data

Summary:

Sedation aggravated is reported as a side effect among people who take Mellaril (thioridazine hydrochloride), especially for people who are female, 30-39 old, have been taking the drug for 2 - 5 years also take Risperdal, and have Pain.

The phase IV clinical study analyzes which people have Sedation aggravated when taking Mellaril. It is created by eHealthMe based on reports of 1,504 people who have side effects when taking Mellaril from the FDA, and is updated regularly.

What is Mellaril?

Mellaril has active ingredients of thioridazine hydrochloride. eHealthMe is studying from 1,516 Mellaril users. Check the latest studies of Mellaril.

What is Sedation aggravated?

Sedation aggravated is found to be associated with 1,161 drugs and 497 conditions by eHealthMe. Check the latest studies of Sedation aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

1,504 people reported to have side effects when taking Mellaril.
Among them, 65 people (4.32%) have Sedation aggravated.

Could Mellaril cause Sedation aggravated?

Among these 65 people:

How long have people been on Mellaril when they have Sedation aggravated? *

What is the gender of people who have Sedation aggravated when taking Mellaril? *

female: 68.75 %
male: 31.25 %

What is the age of people who have Sedation aggravated when taking Mellaril? *

What are other drugs people take besides Mellaril? *

What are other side effects people have besides Sedation aggravated? *

Agitation (state of anxiety or nervous excitement): 21 people, 32.31%
Drug Dependence: 21 people, 32.31%
Speech Impairment (Adult) (inability to speak (adult)): 20 people, 30.77%
Depression: 19 people, 29.23%
Joint Pain: 19 people, 29.23%
Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 19 people, 29.23%
Fatigue (feeling of tiredness): 19 people, 29.23%
High Blood Pressure: 18 people, 27.69%
Galactorrhea (secretion of breast milk in men): 17 people, 26.15%
Hallucination, Auditory (perceiving sounds without auditory stimulus): 17 people, 26.15%

What are the existing conditions these people have? *

Pain: 15 people, 23.08%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 4 people, 6.15%
Bipolar Disorder (mood disorder): 2 people, 3.08%
Tinea Blanca: 1 person, 1.54%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 1.54%
Psychotic Disorder: 1 person, 1.54%
Nausea (feeling of having an urge to vomit): 1 person, 1.54%
High Blood Pressure: 1 person, 1.54%
Depression: 1 person, 1.54%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 1.54%

* Approximation only. Some reports may have incomplete information.

Do you take Mellaril and have Sedation aggravated?

- Check whether Sedation aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mellaril:

Mellaril (1,516 reports)

Browse all side effects of Mellaril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sedation aggravated:

Sedation aggravated (1,161 drugs)

Browse all the conditions that are associated with Sedation aggravated:

Sedation aggravated (497 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on thioridazine hydrochloride (the active ingredients of Mellaril) and Mellaril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.